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Resistin, a proinflammatory adipokine, is elevated in many inflammatory diseases. However, little is known about its performance
in periodontitis. The present study is aimed at evaluating resistin expression and synthesis in periodontal cells and tissues under
inflammatory/microbial stress in addition to its effects on the periodontium. In vivo, 24 male rats were randomly divided into
two groups: control and ligature-induced periodontal disease. After 6 and 12 days, animals were sacrificed to analyze gene
expression of adipokines, bone loss, inflammation, and resistin synthesis. In vitro, human periodontal ligament (PDL)
fibroblasts were used to evaluate the expression of resistin after inflammatory stimuli. In addition, PDL fibroblasts were exposed
to resistin to evaluate its role on soft and hard tissue metabolism markers. The periodontitis group demonstrated significant
bone loss, an increase in the number of inflammatory cells and vascular structures, an increase in resistin expression and
synthesis, and a decrease in the expression of adiponectin, leptin, and its functional receptor. PDL fibroblasts showed a
significant increase in resistin expression and synthesis in response to the inflammatory stimulus by IL-1β. Resistin induced an
increase in cytokine expression and a decrease in the regulation of some hard tissue and matrix formation genes in PDL
fibroblasts. These data indicate that resistin is produced by periodontal cells and tissues, and this effect is enhanced by
inflammatory stimuli. Moreover, resistin seems to interfere with soft and hard tissue metabolism during periodontitis by
reducing markers related to matrix formation and bone tissue.
1. Introduction
Periodontitis is a highly prevalent chronic inflammatory dis-
ease that affects around 42% of the American adult popula-
tion; approximately 10% of the global population is affected
by a severe type [1, 2]. It is initiated and maintained by a dys-
biotic dental biofilm that leads to progressive and irreversible
destruction of the tooth-supporting tissues such as gingiva,
cementum, periodontal ligament, and alveolar bone, result-
ing, eventually, in tooth loss [3]. The inflammatory reaction
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triggered by the host leads to increased production and
release of inflammatory mediators and proteases, which
results in extracellular matrix degradation and alveolar bone
loss [3, 4].
Recently, evidence has been accumulated that periodon-
titis is associated with some systemic conditions and diseases,
such as diabetes mellitus, atherosclerosis, rheumatoid arthri-
tis, and obesity [5–10]. The systemic low-grade inflammatory
state present in obesity may be a pathomechanistic link
between obesity and other chronic inflammatory diseases
such as periodontitis [11]. Adipokines are cytokines with
both anti- and proinflammatory functions that regulate
feeding behavior, energy expenditure, and insulin resis-
tance, and act in immunoinflammatory processes [12].
Among adipokines, resistin has been extensively evaluated
to better understand its role in immunoinflammatory reac-
tions and bone metabolism [13–18]. Serum levels of this
proinflammatory adipokine are elevated in obese patients
[13]. Also, high levels of resistin have been detected in
the gingival crevicular fluid (GCF) of patients with obesity
[14]. Interestingly, resistin levels are also increased in the
GCF of individuals with periodontal disease in the absence
of obesity [14, 15, 19, 20]. Thus, the current evidence
shows elevated levels of resistin, suggesting that this adipo-
kine may play a role in the etiopathology of periodontitis.
Resistin is a cysteine-rich secretory protein expressed in
several human inflammatory resident cells inside and outside
the adipose tissue [16]. In humans, resistin is expressed
mainly by macrophages in response to bacterial and inflam-
matory challenge, such as lipopolysaccharides, proinflamma-
tory cytokines, and to resistin itself, suggesting a role in
inflammation [18, 21, 22]. It has been demonstrated that
resistin plays a role in bone remodeling as it enhances the
proliferation of preosteoblast cells, and also plays a role in
osteoclastogenesis since it increases the number of differenti-
ated osteoclasts [17]. In addition, resistin exerts an angioge-
netic effect on endothelial cells [23] and has strong
proinflammatory effects [18]. Since serum levels of resistin
are elevated in obesity and in systemic diseases such as diabe-
tes mellitus and rheumatoid arthritis, and are also increased
in the GCF and serum of patients with periodontitis, it can
be assumed that resistin increases periodontal inflammation,
thereby increasing the risk of periodontal disease or impair-
ment of periodontal healing [14, 19, 20]. However, little is
known about the explicit role of resistin in the etiopathogen-
esis of periodontitis. Thus, considering the general impor-
tance of adipokines and their relation to inflammatory
diseases, this study is aimed at obtaining more information
about the involvement of resistin in periodontal infection
and inflammation. For this reason, the expression and
synthesis of the proinflammatory adipokine resistin were
examined in periodontal cells and tissues under inflamma-
tory stress, in addition to its effects on the periodontium
in vitro and in vivo.
2. Materials and Methods
2.1. Experimental Protocol. First, we evaluated whether peri-
odontal tissues of rats could express and produce resistin
and other adipokines in the course of experimental peri-
odontitis. The animal experimental protocol (23/2012)
was approved by the local Ethical Committee on Animal
Experimentation and performed in accordance with the
guidelines from the National Council for the Control of
Animal Experimentation (CONCEA). The study protocol
also followed all recommendations of the ARRIVE guide-
lines [24]. An ANOVA test was used to calculate the sam-
ple number based on the results of microcomputed
tomography (micro-CT) analysis performed in a pilot
study. A minimum difference between the means was
determined to have a statistical difference of 6.00μm with
a standard deviation of 2.85μm. Considering a test power
of 0.80 (1 − β = 0:80) and a significance level of α = 0:05, a
minimum of six animals in each group was necessary to
execute the present study. Thus, a total of 24 male adult
Holtzman rats, average weight of 300 g, were maintained
in the animal facilities of the School of Dentistry at Arara-
quara under controlled temperature (22-25°C) with a 12 h
light/dark cycle. Animals were housed in plastic cages and
received standard laboratory diet and water ad libitum.
After 1 week of acclimatization, animals were randomly
divided into two experimental groups: control (sham-oper-
ated) and ligature-induced periodontal disease. At baseline,
animals from the periodontitis group received general
anesthesia by intramuscular injections of 10% ketamine
chlorhydrate (0.08mL/100 g body weight) and 2% xylazine
chlorhydrate (0.04mL/100 g body weight). Cotton thread
ligatures were placed around the cervical area of both
upper first molars and knotted mesially to induce experi-
mental periodontal disease. After 6 and 12 days, all ani-
mals were sacrificed by anesthetic overdose. The
maxillary jaws were hemisected, and one half of the max-
illae including molars with their surrounding tissues were
fixed in 4% paraformaldehyde for 48 h and stored in
70% ethanol for analysis of bone resorption by micro-CT.
Later, these samples (6 hemimaxillae per group and time
point) were decalcified in EDTA (10%, 0.5M) for 2 months
at RT [25–27] and embedded in paraffin for histological pro-
cessing for stereometric and immunohistochemical (IHC)
analyses. The other half of maxillae (6 hemimaxillae per
group and time point) had the gingival tissues around the
maxillary first molars carefully dissected for extraction
of total RNA for real-time polymerase chain reaction
(RT-qPCR).
2.2. Cell Culture and Treatment of Human Periodontal
Fibroblasts. This study and the protocols were approved by
the Ethics Committee of the University of Bonn, and
informed consent was obtained prior to sample collection
(043/11). Human periodontal ligament (PDL) fibroblasts
from up to 9 donors were isolated from periodontally healthy
teeth that were extracted for orthodontic reasons. Briefly,
cells were cultured in Dulbecco’s minimal essential medium
(DMEM, Invitrogen, Karlsruhe, Germany) supplemented
with 10% fetal bovine serum (FBS, Invitrogen), 100U/mL
penicillin, and 100μg/mL streptomycin (Invitrogen) at 37°C
in a humidified atmosphere of 5% CO2. Cells between third
and fifth passage were seeded (5 × 104 cells/well) on six-well
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culture plates and grown to 80% confluence. The medium
was changed every second day. One day prior to the experi-
ments, the FBS concentration was reduced to 1%. Cells were
treated with human recombinant IL-1 beta (IL-1β, Promo-
Kine, Heidelberg, Germany) for 1 day to simulate an inflam-
matory environment. IL-1β was applied at a concentration of
1 ng/mL, which is in the range of levels usually found in the
GCF of periodontally diseased patients. In another experi-
ment, PDL fibroblasts were treated with resistin to evaluate
its role in soft and hard tissue metabolism. A physiological
concentration of resistin (100 ng/mL) was used for PDL
fibroblast stimulation in vitro [15, 28]. Untreated cells served
as a control.
2.3. Alkaline Phosphatase Activity. In order to determine the
role of resistin in potential hard tissue differentiation of PDL
fibroblasts, the alkaline phosphatase (ALP) specific activity
was measured as a function of the release of p-nitrophenol
from a phosphatase substrate, p-nitrophenylphosphate
(pNPP), at pH 10.2 and normalized to total protein in PDL
fibroblast lysates in the presence or absence of resistin after
1 and 6 days. To measure intracellular ALP, cells were lysed
with 0.5% Triton X-100 (Sigma, Munich, Germany) in
phosphate-buffered saline (PBS, Invitrogen) on ice. The cell
lysates were frozen and thawed three times to disrupt the cell
membranes. Then, substrate (2mg/mL pNPP, Sigma) was
added to each sample. The absorbance was determined after
30min of incubation at 37°C with a microplate reader (Power
Wave X; BioTek Instruments, Winooski, VT, USA) at
405nm. ALP activity was expressed as μmol/105 cells/min.
2.4. RT-qPCR. Gene expressions in samples from PDL fibro-
blasts as well as from rat gingival biopsies were analyzed by
quantitative RT-PCR. Total RNA extraction was performed
using RNeasyMini Kit (Qiagen, Hilden, Germany) according
to the manufacturer’s protocol. RNA concentration was
determined by spectrophotometer NanoDrop ND-2000
(Thermo Fisher Scientific, Wilmington, DE, USA), and
500ng of total RNA was reverse-transcribed using iScript™
Select cDNA Synthesis Kit (Bio-Rad Laboratories, Munich,
Germany) according to the manufacturer’s instruction. Anal-
ysis of gene expression of resistin, leptin and its functional
receptor, adiponectin and its receptors, IL-6, IL-8, bone
morphogenetic protein 2 (BMP2), runt-related transcription
factor 2 (RUNX2), osteocalcin (OCN), periostin (POSTN),
collagen I (COL I), transforming growth factor-beta (TGF-
β), and vascular endothelial growth factor (VEGF) was
subsequently performed in triplicate by using QuantiTect
Primers (Qiagen), SYBR Green PCR Master Mix (Bio-Rad
Laboratories), and the thermocycler iCycler iQ™ Real-Time
PCR Detection System (Bio-Rad Laboratories). Amplifica-
tion was carried out under the following conditions: initial
denaturation at 95°C for 5min followed by 40 cycles of dena-
turation at 95°C for 10 s and combined annealing/extension
at 60°C for 30 s. Data were analyzed using the comparative
cycle threshold (CT) method with glyceraldehyde-3-
phosphate dehydrogenase (GAPDH) as the housekeeping
gene.
2.5. Enzyme-Linked Immunosorbent Assay (ELISA). Protein
levels of resistin were measured in cell-free supernatants after
PDL cells were exposed or not to IL-1β for 1 day using a com-
mercially available ELISA kit (RayBio Human Resistin ELISA
Kit, RayBiotech, Norcross, GA, USA) according to the man-
ufacturer’s protocol. The absorbance was determined with a
microplate reader (PowerWave X, BioTek Instruments,
Winooski, VT, USA) at 450nm. For normalization, cells
were collected and counted using an automatic cell counter
(Moelab, Hilden, Germany).
2.6. Micro-CT. Micro-CT analysis was performed on animal
tissues to evaluate the presence of bone destruction after peri-
odontal disease induction. The micro-CT measurements
were performed in accordance with a previous study [29].
A high-resolution micro-CT imaging system Skyscan 1076
(Bruker, Kontich, Belgium) was used with the following
parameters: X-ray generator at 50 kVp, beam current at
500μA, 0.5mm aluminum filtration at an image resolution
of 18μm. The images were reconstructed with the software
NRecon 1.6.1.5 (Skyscan) in all three spatial dimensions,
and then all the maxillae images were orientated and saved
in coronal slices (2000 × 1336) utilizing software Data
Viewer 1.4.3.1 (Skyscan). To measure alveolar bone volume
(BV) and tissue volume (TV), a region of interest (ROI)
was delineated from the root apices to the alveolar crest
and from the mesial root of the first molar to the distal root
of the third molar, excluding the tooth roots and PDL spaces,
comprising the entire alveolar bone, using the despeckle tool
(custom processing) in a software program CT Analyser
1.10.1.0 (Skyscan). The architectural parameter evaluated
was bone volume under tissue volume (BV/TV, %), which
represents the BV fraction.
2.7. Stereometric Analysis. Stereometric analysis was per-
formed to confirm the presence of significant inflammation
in periodontal tissues of animals subjected to periodontitis
induction. Semiserial sections of 5μm were obtained from
the tissue blocks on a mesial-distal orientation. The sections
were processed for regular hematoxylin and eosin (H&E)
staining, and a total of 15 sections were evaluated per tissue
blocks. Each of these 15 sections was spaced 50μm from each
other, in order to be representative of 750μm extension. A
single and blinded examiner, who was trained and calibrated
to the purpose of the experiment, performed the stereometric
analysis using a point-counting technique. This point-
counting technique was used to evaluate the proportion of
the following structures: polymorphonuclear cells, mononu-
clear cells, vascular structures, and other structures on the
H&E-stained sections. Also, macrophages and lymphocytes
were detected and counted by stereometric analysis. For this,
macrophages were considered as round and large cells that
contain a central round nucleus and abundant clear cyto-
plasm, while lymphocytes were considered as round and
small cells that contain large nucleus and small cytoplasm.
One area was assessed between submarginal area and bone
crest area. A 250μm2 square-lattice grid was constructed
using the image software Adobe Photoshop CS5 (San Jose,
CA, USA), and the type of structure found on the intersection
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of the grid lines was counted on an optical microscope
(Cambridge Instruments, Buffalo, NY, EUA) under 200x
magnification. The results were expressed as a percentage
of the total area analyzed.
2.8. IHC Analysis. IHC analysis was performed to evaluate
the production of resistin protein within the periodontal
tissues in the furcation region of first maxillary molars. In
addition, CD3- (a marker of T cells) andMAC387- (a marker
of macrophages) positive cells were evaluated. Serial
parasagittal sections with 5μm thickness were mounted on
silanized slides Dako A/S (Glostrup, Denmark). The IHC
analysis was performed according to a previous study [25].
The sections were incubated with rabbit polyclonal antibody
anti-resistin (1 : 100, ab216840, Abcam, Cambridge,
England), rabbit polyclonal antibody anti-CD3 (1 : 100,
ab5690, Abcam), and mouse monoclonal antibody macro-
phage marker (1 : 50, sc66204, Santa Cruz Biotechnology,
Santa Cruz, CA, USA) at 4°C overnight. Negative control sec-
tions were instead incubated with 1% PBS to assess unspecific
background staining. After the incubation period, the tissue
sections were washed and incubated with biotinylated immu-
noglobulin (Dako) at room temperature for 30min and sub-
sequently washed again and incubated with avidin-biotin
peroxidase complex (Dako) at room temperature for
30min. Diaminobenzidine (DAB, Dako) was used as a chro-
mogen substrate. All sections were counterstained with Car-
razi’s hematoxylin. Photomicrographs of the most coronal
portion of the furcation region were taken using a light
microscope LEICA microsystem GmbH (Wetzlar, Germany)
at 200x magnification. Cells positive for resistin, CD3, and
MAC387 present in the furcation region were counted by a
blinded and calibrated examiner.
2.9. Data Analysis. Statistical analyses were performed using
a software program GraphPad Prism 5 (GraphPad Software
Inc., San Diego, CA, USA). For all analyses, data were synthe-
sized using mean values and standard deviations of the
means. To determine any significant difference between
groups, a t-test and ANOVA followed by Dunnett’s test were
used for the in vivo study, and a Mann–Whitney U test was
used for the in vitro study. Significant differences were con-
sidered when p < 0:05.
3. Results
3.1. Pathophysiological Changes in Hard and Soft Tissues
during Experimental Periodontitis. As analyzed by micro-
CT, ligature-induced periodontitis resulted in substantial
alveolar bone loss (p < 0:05, Figures 1(a) and 1(b)). Stereo-
metric analysis indicates that periodontal disease is associ-
ated with a sustained inflammatory reaction between
submarginal area and bone crest area. Inflammation was
studied by the relative presence of inflammatory cells and
vascular structures in a 500μm2 area in a minimum of 15 sec-
tions (500 points). The density (%) of neutrophils, mononu-
clear cells, and vascular structures increased at day 12 for the
ligature-induced periodontal disease model (Table 1). Also,
the stereometrics analysis showed an increase in the number
of macrophages and lymphocytes in the periodontitis group
at 12 days (Table 1). IHC analysis was used to validate the
inflammation found in the stereometric analysis. The result
showed that in the periodontitis group, there was a signifi-
cant number of cells positive for CD3 (Figures 1(c)–1(e))
and MAC387 (Figures 1(f)–1(h)) after 6 and 12 days of the
disease beginning as compared to the control group.
3.2. Expression of Adipokines and Their Receptors in
Periodontal Tissues and Cells.When compared to the control
group, the periodontitis group presented in the gingival tis-
sue samples a significant (p < 0:05) increase in mRNA
expression of resistin and a significant (p < 0:05) decrease
in mRNA expression of adiponectin as well as of leptin and
its functional receptor (Figures 2(a)–2(d)). Interestingly,
expression of the adiponectin receptors R1 and R2 was not
changed in the presence of periodontitis (Figures 2(e) and
2(f)). In addition, as detected by IHC, a significantly
(p < 0:05) enhanced number of resistin-positive cells was
found in the furcation region of the periodontitis samples
as compared to the control group (Figure 3(c)).
Moreover, the in vitro experiment also showed that peri-
odontal cells produced resistin under inflammatory condi-
tions. Specifically, in the presence of IL-1β, PDL fibroblasts
presented significantly (p < 0:05) more resistin expression
(Figure 4(a)) and protein synthesis (Figure 4(b)).
3.3. Effect of Resistin on Critical Cell Functions of Periodontal
Homeostasis. After having found that resistin was increased
in periodontal cells and tissues under inflammatory and
microbial stress, we next focused on studying the effects of
resistin on human periodontal cells. These cells showed a sig-
nificant increase in the expression of IL-6 and IL-8 after
treatment with resistin, indicating an inflammatory effect
(Figure 4(c)). Then, we sought to analyze the effect of resistin
on hard tissue differentiation by evaluating the ALP activity
in PDL fibroblasts incubated with resistin for 1 and 6 days.
In the presence of resistin, ALP activity was significantly
(p < 0:05) reduced at 1 d, as demonstrated in Figure 5(a). At
6 d, there was no significant difference (data not shown). A
wide range of resistin concentrations caused a significant
(p < 0:05) reduction of BMP2 mRNA expression after 1 day
(Figure 5(c)). In addition, we studied the regulation of other
hard tissue markers (BMP2, RUNX2, and OCN), matrix
markers (POSTN and COL I), and growth factors (TGF-β
and VEGF) involved in bone metabolism. All these molecu-
lar markers were downregulated in PDL fibroblasts after 1
and 3 days of incubation with resistin (Figures 5(c) and 5(d)).
4. Discussion
This study provides detailed evidence that resistin is pro-
duced locally in periodontal cells and tissues, with a remark-
able increase as a result of inflammatory/infectious stress. In
addition, this adipokine has negative/detrimental effects or
interferes negatively with soft and hard tissue metabolism
due to a decrease in matrix and bone markers and growth
factors.
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Interestingly, resistin has already been demonstrated to
be expressed in PDL cells [30]. Our present study confirms
that periodontal cells and tissues are able to produce resistin.
More importantly, our study revealed that the resistin
expression in PDL cells is upregulated in the presence of
the proinflammatory mediator IL-1β. Likewise, experimental
periodontitis in rats resulted in the upregulation of resistin in
gingival tissues and increased resistin protein production in
the periodontium. In accordance with our results, resistin
has been observed in human gingival fibroblasts treated with
Porphyromonas gingivalis and in gingival biopsies from gin-
givitis and periodontitis patients [31]. Moreover, our study
showed a proinflammatory potential of resistin in increasing
the expression of IL-6 and IL-8 in periodontal cells. Taken
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Figure 1: (a) Representative two-dimensional micro-CT lateral views of maxillary molars of one animal from the control group and one
animal from the periodontitis group at 12 days. (b) Comparison of BVF percentage measured in a selected ROI of the maxillary first
molars and the mesial roots of the second molars using micro-CT. Results are expressed as the mean ± SD (n = 6). The periodontitis
group showed a decrease in BVF compared to the control group at 6 and 12 days. ∗Significant difference (p < 0:05). Representative images
(400x magnification) showing the IHC analysis performed in the first maxillary molars of rats from the control group (c) and
periodontitis group (d) marked with CD3, and the control group (f) and periodontitis group (g) marked with MAC387. Results are
expressed as the mean ± SD (n = 6). The graphs show an increase in the number of cells positive for CD3 (e) and MAC387 (h) in the
periodontitis group in comparison to the control group after 6 and 12 days. ∗Significant difference (p < 0:05).
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together, these data suggest that resistin is increased after
microbial and inflammatory conditions. Furthermore, in
addition to inflammatory cells such as macrophages, PDL
fibroblasts may contribute to the increased resistin levels
found in the GCF of periodontal patients, as we have pro-
vided not only gene expression but also protein synthesis of
resistin, suggesting that resistin induces proinflammatory
cytokine production in periodontal cells. Therefore, resistin
may play a role in the pathology of periodontitis.
Periodontitis is a chronic inflammatory disease initiated
by bacterial infection, which activates the host immune
response by a cascade of inflammatory events such as the
release of proinflammatory cytokines. Some studies have
demonstrated elevated levels of resistin in the GCF of peri-
odontitis patients compared to nonperiodontitis patients
[15, 19, 28]. This high resistin level in the GCF during peri-
odontitis could be explained by the quantity of PDL fibro-
blasts in addition to inflammatory cells, especially
macrophages. As we could see, the IHC analysis of the
in vivo samples showed a significant increase in the number
of macrophages and lymphocytes in the periodontitis group
as compared to control, which, although not further evalu-
ated, could have been contributed to the increased resistin
levels in the inflamed periodontal tissues. Moreover, as
already demonstrated by other investigators, resistin stimu-
lates the production of proinflammatory cytokines in adipose
tissue and in peripheral blood mononuclear cells and, on the
other hand, the expression of resistin is also stimulated by
proinflammatory cytokines in the cited tissue and cells show-
ing a positive feedback loop for resistin [18, 32, 33]. In our
study, although this feedback loop was not evaluated, we
could assume it is also happening in periodontal cells and
tissues.
Interestingly, our study showed that resistin does inter-
fere negatively with ALP activity by significantly reducing
its expression. In addition, resistin induces downregulation
of hard tissue (BMP2, RUNX2, and OCN) and matrix
(POSTN and COL I) markers and growth factors (TGF-β
and VEGF) in periodontal cells. Although limited, our results
suggest an impairment effect of resistin on periodontal
remodeling. For this reason, resistin could be involved in
the tissue destruction presented in periodontal disease via
increased expression in periodontal cells and tissues after
inflammatory and infectious stimuli and by affecting the
metabolism of soft and hard tissues due to inhibition of mol-
ecules involved in hard and soft tissue formation.
Evidence indicates that resistin is present in other cell
types and has a role in bone metabolism. Murine preosteo-
clasts RAW 264.7, murine preosteoblasts MC3T3-E1, human
bone marrow mesenchymal stem cells, and human osteo-
blasts express resistin [17]. Resistin stimulates osteoclast dif-
ferentiation in both murine preosteoclasts and human
monocytes and increases osteoblast proliferation. In addi-
tion, an indirect stimulatory effect of resistin on osteoclasto-
genesis can be observed by decreasing the RANKL/OPG
mRNA ratio and by increasing IL-6 production [17]. Besides
that, resistin was found in osteoblasts and osteoclasts from
human osteoarthritis osteophytes. However, when these cells
were stimulated with resistin, there was no significant effect
on cytokine secretion [34]. Increased levels of resistin were
found in human neutrophils stimulated with P. gingivalis
LPS [15]. Also, resistin induces the production of cytokines
and chemokines in human articular chondrocytes [35]. Fur-
thermore, resistin induces the release of proinflammatory
cytokines, such as IL-6 and TNF-α, in human peripheral
blood mononuclear cells [18]. Resistin may affect directly
and indirectly bone metabolism; thus, it would be interesting
to evaluate the effect of resistin on osteoblasts using bone
remodeling assays in the future.
Regarding the other adipokines evaluated in the present
study, leptin and its functional receptor were significantly
downregulated in gingival tissues in periodontitis. Our previ-
ous study conducted regarding the role of leptin in periodon-
tal regeneration corroborates the present findings as it
showed that leptin is produced by PDL cells, and bacterial/in-
flammatory stimuli significantly decrease leptin synthesis
[36]. Furthermore, the gingival tissues showed significantly
reduced expression of adiponectin in periodontitis, although
no change was observed for its receptors compared to the
control group. Interestingly, a study from our group showed
that P. gingivalis suppresses adiponectin expression in PDL
cells while stimulating the expression of its receptors [37].
Also, downregulation of adiponectin and increased expres-
sion of its receptors have been observed in gingival tissues
of periodontal patients as compared to periodontal healthy
ones [31]. All these findings are in agreement with previous
studies that also found decreased levels of adiponectin in
the serum of periodontitis patients [25, 38]. In contrast, gin-
gival fibroblasts treated with TNF-α showed significant
reduction in the expression of adiponectin receptors as well
as periodontal tissues from severe periodontitis patients
compared to healthy ones [39]. Thus, the exact regulation
and role of adiponectin receptors in periodontitis are still
contradictory.
During periodontal disease progression, many molecules
induce a cascade of events to initiate and maintain a chronic
immunoinflammatory response in the periodontium respon-
sible for the destruction of soft and hard tissues [4, 40]. In the
present study, the experimental periodontitis model has
accomplished its objective as we could see significant alveolar
bone loss in the periodontitis group in line with a significant
increase in the percentage of inflammatory cells and vascular
Table 1: Mean (±SD) of the percentage of polymorphonuclear cells,
mononuclear cells, vascular structures, other structures,
lymphocytes, and macrophages on H&E-stained sections of each
experimental group.
Control Periodontal disease
Polymorphonuclear cells 2:57 ± 0:70 25:19 ± 5:10∗
Mononuclear cells 2:89 ± 1:18 51:89 ± 3:51∗
Vascular structures 3:12 ± 1:24 13:66 ± 2:45∗
Other structures 92:15 ± 9:32 9:26 ± 1:25∗
Lymphocytes 0:98 ± 0:46 22:71 ± 2:18∗
Macrophages 1:91 ± 0:67 29:18 ± 3:21∗
∗p < 0:05 statistically different compared to control.
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Figure 2: Resistin (a), leptin (b), leptin receptor (c), adiponectin (d), adiponectin receptor 1 (e), and adiponectin receptor 2 (f) mRNA
expression in rat gingival biopsies after 6 and 12 days of ligature-induced experimental periodontitis around the first maxillary molars
compared to expression in healthy controls. Results are expressed as the mean ± SD (n = 6). ∗Significant difference (p < 0:05).
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Figure 3: Representative images (100x magnification) of IHC staining for resistin in the first maxillary molars of rats from the control and
periodontitis groups (a). Representative image (400x magnification) showing in greater scale some cells positive for resistin pointed by black
arrows in the periodontitis group (b). Results are expressed as the mean ± SD (n = 6). The graph shows an increase in the number of cells
positive for resistin in comparison to the control group (c). ∗Significant difference (p < 0:05).
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structures, and with a decrease in the extracellular matrix and
fibroblast cells.
Rodent and human resistin share around 60% of the
sequence homology at the amino acid level. Furthermore,
their resistin genes have notably different promoter regions,
suggesting that the regulation and function of resistin is dif-
ferent between rodents and humans [41, 42]. Therefore,
whether the effect of resistin on rodents is translatable to
human has not been completely confirmed. However, ele-
vated resistin levels have been observed in serum and gingival
crevicular fluid of periodontitis patients in clinical studies
[14, 19, 43]. That the regulation of resistin in human and
rodent periodontia might be similar is also supported by
our findings which showed increased resistin expression in
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Figure 4: Effect of IL-1β (1 ng/mL) on resistin mRNA expression (a) and protein levels (b) in PDL fibroblasts after 1 day as determined by
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Figure 5: (a) Effect of resistin (100 ng/mL) on ALP activity in PDL fibroblasts after 1 day. ALP activity was significantly reduced in the
presence of resistin (n = 3). (b) Effect of resistin (30, 100, and 300 ng/mL) on BMP2 mRNA expression in PDL fibroblasts after 1 day
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difference (p < 0:05).
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rat experimental periodontitis and elevated resistin levels in
human PDL fibroblasts after exposure to a proinflammatory
mediator. We cannot extrapolate to humans the results from
animal studies; however, we can speculate after careful data
analysis from a variety of animal studies and make a cross-
species translation. Therefore, the quality of animal studies
is extremely important to improve study design and conduc-
tion beyond to minimize biases in publication.
The cell type used in our study, PDL fibroblasts, presents
a phenotype that enables it to be used for hard tissue forma-
tion analyses due to their established ability in developing
mineralized nodules in vitro and to express bone-associated
markers.
The concentration of resistin used in our study was in the
range of the physiological concentration of resistin found in
human GCF [15, 19, 28] and used to stimulate other types
of cells in in vitro studies [44–46]. Also, as in our previous
studies, IL-1β was used in vitro in order to mimic inflamma-
tory conditions because its increased production in peri-
odontal sites has been demonstrated [36, 40].
5. Conclusions
In summary, the present study shows that resistin is pro-
duced by periodontal cells and tissues. In addition, microbial
and inflammatory stimuli increase resistin expression and
production in the periodontium. Moreover, resistin seems
to interfere with soft and hard tissue metabolism during peri-
odontitis by reducing ALP activity and markers related to
bone tissue and matrix formation. However, further studies
using specific resistin inhibitors and/or knockout animals
could allow a better elucidation of the harmful role of resistin
in inflammatory diseases such as periodontitis.
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